Today: 10 June 2026
CrowdStrike stock today: CRWD slides as cybersecurity sector lags Wall Street
2 January 2026
1 min read

CrowdStrike stock today: CRWD slides as cybersecurity sector lags Wall Street

NEW YORK, January 2, 2026, 12:51 ET — Regular session

  • CrowdStrike shares fell 3.6% to $451.74 in midday trading after opening the year on the back foot.
  • Cybersecurity ETFs lagged, with Global X Cybersecurity (BUG) down about 2.2%.
  • Peers Zscaler and SentinelOne were down more than 4%, adding to pressure on the group.

CrowdStrike Holdings, Inc. shares were down 3.6% at $451.74 on Friday, sliding more than the broader market as cybersecurity stocks pulled back on the first regular session of 2026.

The move matters because investors often reset portfolios at the start of a new year, and richly valued software names can see outsized swings when risk appetite shifts.

Macro focus is also returning after the holidays. Reuters reported investors are bracing for a batch of delayed U.S. economic releases and watching for fresh signals on the Federal Reserve’s policy path — factors that can quickly reprice growth stocks.

Broader U.S. stocks were mixed as the session progressed, with Reuters describing early gains fading after the opening bell.

Sector gauges showed the weakness was not confined to one name. The Global X Cybersecurity ETF was down about 2.2%, while the HACK cybersecurity ETF fell about 1.4%.

Peer stocks were also under pressure. Zscaler and SentinelOne were off more than 4%, and Fortinet slid about 2%, while Palo Alto Networks was modestly lower.

“When you turn the page for a new year … you’re waiting to see … the vibe for the coming year,” said Thomas Martin, senior portfolio manager at Globalt.

CrowdStrike traded between $449.49 and $467.07 on the day, after opening at $464.70. About 3.9 million shares had changed hands by midday.

The stock remains about 23% below its 52-week high of $586.77, even after gaining roughly 76% from its 52-week low of $256.70 — a setup that can attract profit-taking when the sector cools.

CrowdStrike sells its Falcon platform — cloud-delivered software that helps companies detect and respond to intrusions — on a subscription model that aims to generate recurring revenue.

In its last earnings update in early December, CrowdStrike forecast stronger fourth-quarter revenue as demand benefited from customers adopting AI across security workflows, Reuters reported.

What investors are watching next is the company’s next set of results after its Jan. 31 fiscal year-end, with attention likely on annual recurring revenue (ARR) — the subscription revenue base expected over 12 months — and customer retention.

For the rest of Friday’s session, the $450 level is in focus after the stock briefly slipped below it. Traders will also be watching incoming U.S. data for rate-cut expectations and the market’s appetite for high-growth software into the first full week of 2026.

Stock Market Today

  • Is Altria Group (MO) Still a Buy After Recent Share Price Gains?
    June 10, 2026, 8:47 AM EDT. Altria Group (MO) has seen a 30.8% return over the past year, sparking debate on its valuation amid industry shifts. Using a Discounted Cash Flow (DCF) model, Altria is valued at approximately $128.50 per share, suggesting it trades at a 44.3% discount to intrinsic value based on projected future cash flows. This implies the stock is undervalued despite recent gains. Investors weigh factors like the growth of reduced-risk tobacco products, regulatory changes, and capital allocation strategies. Simply Wall St's six-point valuation framework rates Altria 4 out of 6, supporting cautious optimism. The P/E ratio and other valuation metrics are considered to assess if current prices fairly reflect fundamentals. This analysis provides investors a data-backed perspective on Altria's potential upside and risks.

Latest articles

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Shares Fall Again; Microsoft AI Cloud Agreement Still in Focus

10 June 2026
IREN plunged 8.73% to $54.02 Tuesday and slid another 3.72% premarket as investors weighed Wall Street’s bullish calls on its AI cloud buildout against a tech and crypto selloff; the stock’s fate now hinges on IREN’s ability to deliver Microsoft- and Nvidia-linked AI infrastructure on schedule, with the Microsoft contract at risk if timelines slip.
Interstellar comet 3I/ATLAS spills its secrets as scientists clock its water loss and radio silence
Previous Story

Interstellar comet 3I/ATLAS spills its secrets as scientists clock its water loss and radio silence

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal
Next Story

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal

Go toTop